UnitedHealth Group Incorporated $UNH Holdings Lowered by Meiji Yasuda Life Insurance Co

Key Points

• Meiji Yasuda Life Insurance Co reduced its holdings in UnitedHealth Group by 4.1%, now owning 42,182 shares valued at approximately $22 million, making it the company's 20th largest holding.
• Several hedge funds made significant adjustments to their positions in UnitedHealth Group, including GAMMA Investing LLC, which increased its stake by 56,142.1%.
• Analysts have recently revised ratings and price targets for UnitedHealth Group, with a consensus average rating of "Moderate Buy" and a target price of $354.86.

Meiji Yasuda Life Insurance Co reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,182 shares of the healthcare conglomerate's stock after selling 1,799 shares during the period. UnitedHealth Group comprises about 0.4% of Meiji Yasuda Life Insurance Co's holdings, making the stock its 20th largest holding. Meiji Yasuda Life Insurance Co's holdings in UnitedHealth Group were worth $22,093,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. GAMMA Investing LLC raised its stake in shares of UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Nuveen LLC acquired a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $3,846,764,000. Vanguard Group Inc. lifted its position in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the period. Wellington Management Group LLP lifted its position in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

UNH has been the subject of a number of analyst reports. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a research note on Monday, May 19th. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Piper Sandler dropped their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Finally, Oppenheimer reduced their price target on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $354.86.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Trading Up 1.5%

Shares of UNH stock opened at $315.10 on Monday. The stock has a market capitalization of $285.38 billion, a price-to-earnings ratio of 13.65, a PEG ratio of 2.04 and a beta of 0.44. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company's fifty day simple moving average is $288.78 and its two-hundred day simple moving average is $372.56. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the company posted $6.80 EPS. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.